Skip to content
KAICO Ltd. logo

KAICO Ltd. Alternatives & Competitors

12 companies similar to KAICO Ltd. — Changing the World with Silkworms

Companies similar to KAICO Ltd.

Novavax logo — alternative to KAICO Ltd.

Novavax

Powering innovation. Protecting health.

Stablepharma Limited logo — alternative to KAICO Ltd.

Stablepharma Limited

Stablepharma develops fridge-free, extended shelf-life versions of vaccines and pharmaceut...

Synbio Technologies logo — alternative to KAICO Ltd.

Synbio Technologies

Changing the world, one sequence at a time.

BALTYMAS logo — alternative to KAICO Ltd.

BALTYMAS

Excellence in native recombinant proteins

Rival Readout

Competing with KAICO Ltd.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Nuclera logo — alternative to KAICO Ltd.

Nuclera

Bring rapid protein access to your benchtop with eProtein Discovery

Ochre Bio logo — alternative to KAICO Ltd.
Avilar Therapeutics logo — alternative to KAICO Ltd.

Avilar Therapeutics

Pioneering the discovery and development of extracellular protein degraders.

HilleVax logo — alternative to KAICO Ltd.

HilleVax

HilleVax is a biopharmaceutical company focused on the development and commercialization o...

Walvax logo — alternative to KAICO Ltd.

Walvax

Help everyone live a healthy life!

ViroVet logo — alternative to KAICO Ltd.

ViroVet

Please follow us on X (@ViroVet) or check our website for news about ViroVet

TheraJect, Inc. logo — alternative to KAICO Ltd.

TheraJect, Inc.

Enhancing Vaccine Efficacy and Expanding Global Access with Innovative, Needle-Free Transd...

Be Biopharma logo — alternative to KAICO Ltd.

Be Biopharma

Engineered B cells as medicines

About KAICO Ltd.

KAICO Ltd., founded in 2018, is a pioneering Japanese biotechnology startup that leverages its proprietary silkworm-baculovirus expression system to develop and produce recombinant proteins. By utilizing silkworms as bioreactors, KAICO offers a scalable and speedy solution for protein production, bypassing the need for...

Services

Protein Expression Service, Custom Protein Expression Trial Services, Veterinary and Human Vaccine Development, Research Reagents and Supplements

Target Customers

Pharmaceutical Companies, Biotechnology Researchers, Veterinary Health Organizations, Human Healthcare Providers

Business keywords

Recombinant Proteins, Silkworm-Baculovirus Expression System, Bioreactor, Scalable Production, Rapid Production, Oral Vaccines, Public Health, Animal Health, Livestock Productivity, Cold-chain Independence, Non-injectable Vaccines, Biopharmaceuticals, Diagnostic Drug Production

Business Model

B2B, B2D, B2C

Revenue Model

Product Sales, Service Fee, Licensing

Frequently Asked Questions

Companies similar to KAICO Ltd. include Novavax, Stablepharma Limited, Synbio Technologies, BALTYMAS, Nuclera. They work in Biotechnology and Pharmaceutical and share KAICO Ltd.'s focus on public health, recombinant proteins and animal health.
Bounce Watch lists 12 companies that share KAICO Ltd.'s industries and are closest to it in business tags, services, target customers, business model and size.
KAICO Ltd., founded in 2018, is a pioneering Japanese biotechnology startup that leverages its proprietary silkworm-baculovirus expression system to develop and produce recombinant proteins. By utilizing silkworms as bioreactors, KAICO offers a scalable and speedy solution for protein production, bypassing the need for...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around KAICO Ltd.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at KAICO Ltd. on 13 Nov 2025. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout